Benefits versus risks of latest therapies in multiple sclerosis: a perspective review. Ontaneda D, Di Capua D Ther Adv Drug Saf. 2012 Dec; 3(6):291-303. PMID: 25083243. Abstract CommentRecommendBookmarkWatch